Lopa Mishra

Lopa Mishra

George Washington University

H-index: 64

North America-United States

About Lopa Mishra

Lopa Mishra, With an exceptional h-index of 64 and a recent h-index of 37 (since 2020), a distinguished researcher at George Washington University, specializes in the field of Cancer Stem cells, liver and gastrointestinal cancers.

His recent articles reflect a diverse array of research interests and contributions to the field:

Iguratimod, an allosteric inhibitor of macrophage migration inhibitory factor (MIF), prevents mortality and oxidative stress in a murine model of acetaminophen overdose

CEACAM1 induces microbiome and metabolite driven diversion of TGF-β signaling to promote colon cancer

A TGF-β superfamily member, myostatin contributes to MASH and HCC via muscle atrophy by disrupting TGF-β signaling, and is a potential marker with PKM2 for human HCC

Loss of SIRT6 diverts TGF-β signaling to promote liver cancer

Targeting liver specific βII-Spectrin to prevent the development of metabolic dysfunction associated steatohepatitis (MASH) through CEACAM1 axis

Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma

Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis

B-spectrin (sptbn1) deficiency protects mice from high-fat diet-induced liver disease and cancer development

Lopa Mishra Information

University

Position

Professor of Surgery

Citations(all)

15881

Citations(since 2020)

8306

Cited By

10841

hIndex(all)

64

hIndex(since 2020)

37

i10Index(all)

132

i10Index(since 2020)

94

Email

University Profile Page

Google Scholar

Lopa Mishra Skills & Research Interests

Cancer Stem cells

liver and gastrointestinal cancers

Top articles of Lopa Mishra

Iguratimod, an allosteric inhibitor of macrophage migration inhibitory factor (MIF), prevents mortality and oxidative stress in a murine model of acetaminophen overdose

Molecular Medicine

2024/3/27

CEACAM1 induces microbiome and metabolite driven diversion of TGF-β signaling to promote colon cancer

Cancer Research

2024/3/22

A TGF-β superfamily member, myostatin contributes to MASH and HCC via muscle atrophy by disrupting TGF-β signaling, and is a potential marker with PKM2 for human HCC

Cancer Research

2024/3/22

Lopa Mishra
Lopa Mishra

H-Index: 40

Loss of SIRT6 diverts TGF-β signaling to promote liver cancer

Cancer Research

2024/3/22

Targeting liver specific βII-Spectrin to prevent the development of metabolic dysfunction associated steatohepatitis (MASH) through CEACAM1 axis

Cancer Research

2024/3/22

Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma

2024/3/1

Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis

Genes & Cancer

2024

B-spectrin (sptbn1) deficiency protects mice from high-fat diet-induced liver disease and cancer development

2023/12/28

β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy

Frontiers in Immunology

2023/9/8

Vivek Shukla
Vivek Shukla

H-Index: 7

Lopa Mishra
Lopa Mishra

H-Index: 40

Hepatocellular Carcinoma Genetic Classification

2023/9/1

Lopa Mishra
Lopa Mishra

H-Index: 40

Mo1900 TARGETING INTRINSICALLY DISORDERED PROTEIN βII-SPECTRIN INHIBITS REACTIVE ALDEHYDE-ASSOCIATED METABOLIC SYNDROME AND HCC

Gastroenterology

2023/5/1

1161 POTENTIAL MODULATION OF PKM2 IN HEPATIC MACROPHAGE REGULATION OF NASH AND HCC VIA TGF-b SIGNALLING.

Gastroenterology

2023/5/1

1227 A NOVEL CLINICAL AND BIOMARKER MODEL BASED ON TGF-B SUPERFAMILY SIGNALING PROTEINS IMPROVES ON AFP AND THE DOYLESTOWN MODEL IN PREDICTING HEPATOCELLULAR CARCINOMA ACROSS …

Gastroenterology

2023/5/1

1160 CROSS-TALK BETWEEN THE GUT MICROBIOME, CEACAM'S, AND TGF-β SIGNALLING IN GASTROINTESTINAL CANCERS

Gastroenterology

2023/5/1

A novel clinical and biomarker model accurately predicts hepatocellular carcinoma (HCC) across racial groups

Cancer Research

2023/4/4

Herbert Yu
Herbert Yu

H-Index: 51

Lopa Mishra
Lopa Mishra

H-Index: 40

Targeting intrinsically disordered protein βII-spectrin prevents metabolic syndrome and hepatocellular carcinoma on a sex-based bias

Cancer Research

2023/4/4

Xiaochun Yang
Xiaochun Yang

H-Index: 9

Lopa Mishra
Lopa Mishra

H-Index: 40

Impact of sex differences on cross-talk between the gut microbiome, CEACAMs, and TGF-β signaling in cancers

Cancer Research

2023/4/4

PKM2 Modulates hepatic macrophage regulation of NASH, ferroptosis and HCC through TGF-β signaling

Cancer Research

2023/4/4

Isolation of nuclei from human snap-frozen liver tissue for single-nucleus RNA sequencing

Bio-protocol

2023/2/2

Lopa Mishra
Lopa Mishra

H-Index: 40

Immunotherapy for hepatocellular carcinoma in the setting of liver transplantation: A review

2023/1/25

Lopa Mishra
Lopa Mishra

H-Index: 40

See List of Professors in Lopa Mishra University(George Washington University)